US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma.

IF 2 3区工程技术 Q3 CHEMISTRY, MULTIDISCIPLINARY

Journal of Chemical & Engineering Data Pub Date : 2024-11-20 Epub Date: 2024-07-25 DOI:10.1200/JCO.24.00100

Edward R Scheffer Cliff, David A Russler-Germain, C Joseph Ross Daval, Aaron S Kesselheim

引用次数: 0

Abstract

The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma.

查看原文本刊更多论文

美国食品和药物管理局处理延迟确认试验的指令：从治疗 T 细胞淋巴瘤的 Pralatrexate 和 Belinostat 中汲取的教训。

美国食品药品管理局关于处理延迟确证试验的指令：从治疗 T 细胞淋巴瘤的 pralatrexate 和 belinostat 中汲取的教训。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Chemical & Engineering Data 工程技术-工程：化工

CiteScore

5.20

自引率

19.20%

发文量

324

审稿时长

2.2 months

期刊介绍： The Journal of Chemical & Engineering Data is a monthly journal devoted to the publication of data obtained from both experiment and computation, which are viewed as complementary. It is the only American Chemical Society journal primarily concerned with articles containing data on the phase behavior and the physical, thermodynamic, and transport properties of well-defined materials, including complex mixtures of known compositions. While environmental and biological samples are of interest, their compositions must be known and reproducible. As a result, adsorption on natural product materials does not generally fit within the scope of Journal of Chemical & Engineering Data.